• O-GlcNAcylation and Galectin-3 in XEN Differentiation

  2026-09-18

  Gatie and colleagues show that extraembryonic endoderm differentiation is accompanied by reduced global O-GlcNAcylation but increased relative secretion of galectin-3. The study separates overall protein abundance from extracellular partitioning and finds that experimentally maintaining O-GlcNAcylation is not sufficient to prevent embryonic stem-cell differentiation toward the XEN lineage.

• AG-126: From ERK Inhibition to Circuit Assays

  2026-09-17

  AG-126 (Tyrphostin AG-126) is a selective ERK1/2 phosphorylation inhibitor that can sharpen studies of inflammatory and neuronal signaling. This article presents an evidence-based assay framework connecting pathway pharmacology with Neuroligin 1–D2-MSN research without overstating translational conclusions.

• Olaparib (AZD2281) DNA Damage Workflows

  2026-09-17

  Build more informative PARP inhibition experiments with Olaparib (AZD2281), from BRCA-stratified viability assays to radiation-response studies and PAR-dependent condensate models. The workflow combines controlled dosing, orthogonal DNA damage readouts, and cation-aware phase-separation controls to distinguish catalytic inhibition from assay artifacts.

• Betulinic Acid Protects Against CYP Liver Injury via ERK

  2026-09-17

  This study identifies an ERK-linked mitochondrial apoptotic mechanism underlying cyclophosphamide-induced liver injury and shows that betulinic acid reduces oxidative damage in mice. Its integrated analysis of NRF2, MAPK signaling, mitochondrial dynamics, and apoptosis provides a useful framework for evaluating pathway-directed hepatoprotection, including pharmacological interrogation with PD98059.

• Human SAN–Cardiac Plexus Assembloids

  2026-09-16

  This reference study develops human pluripotent stem cell-derived assembloids that connect sinoatrial node, cardiac plexus, and atrial-like tissues to model innervation-associated pacemaker maturation. By combining electrophysiology with human SAN spatial transcriptomics, the authors identify a prosaposin–GPR37 signaling program that links neural inputs to pacemaker development and conduction.

• GDC-0994: ERK1/2 Inhibitor Research Guide

  2026-09-15

  GDC-0994 is a potent, selective ERK1/2 inhibitor for studying MAP kinase signaling in cancer and liver-injury models. Its reported biochemical potency, pathway readouts, formulation properties, and zebrafish rescue evidence support mechanistic research rather than clinical treatment claims.

• iRhom2 in Olfaction: OR Regulation and Adaptation

  2026-09-14

  This study identifies iRhom2 as a distinctive regulator in mouse olfactory sensory neurons, linking odorant receptor expression with activity-dependent adaptation. Its combination of transcriptomics, spatial validation, and receptor signaling experiments suggests an odor-responsive iRhom2/ADAM17 feedback pathway while also defining important limits on causal interpretation.

• ROS-Responsive LNPs for Tumor-Selective mRNA Delivery

  2026-09-14

  Cai and colleagues developed a library of thioketal-containing, ROS-degradable lipids to improve tumor-selective mRNA delivery. Screening identified BAmP-TK-12, which released mRNA more effectively in cancer cells and enabled DUF5-mediated depletion of mutant RAS, producing stronger antitumor activity than a small-molecule RAS inhibitor in the reported models.

• AG-126: ERK Signals at the Neurobehavioral Edge

  2026-09-13

  AG-126 provides a pharmacological entry point for testing whether ERK1/2 signaling contributes to the cellular and inflammatory context of repetitive behavior, while keeping the distinction between established evidence and neurobehavioral hypothesis testing explicit.

• Jasplakinolide: Interpreting Actin Perturbation

  2026-09-12

  Jasplakinolide is an actin polymerization inducer that can reveal how filament stability shapes cellular phenotypes. This guide combines molecular mechanism, assay design, and chemical-genetic reasoning to improve interpretation beyond simple cytoskeletal imaging.

• Tacalcitol monohydrate Research Workflows

  2026-09-12

  Tacalcitol monohydrate supports controlled VDR-driven studies spanning keratinocyte biology, NGF induction, and colorectal cancer research. This practical guide shows how to build reproducible concentration-response, 5-fluorouracil combination, and mechanism-focused assays while avoiding common formulation and interpretation errors.

• DDM and the Next Era of Integrin Structural Biology

  2026-09-11

  Full-length αvβ3 integrin is not a single static receptor but a conformational ensemble. This thought-leadership article explains how n-Dodecyl-β-D-maltoside can support membrane-protein workflows while showing translational researchers how to treat detergent composition as an experimental variable rather than a routine formulation detail.

• PD0325901: Reliable MEK Inhibition in Cell Assays

  2026-09-11

  Learn how PD0325901 (SKU A3013) can help researchers separate genuine MEK-pathway biology from formulation and assay variability. This scenario-based guide covers solvent control, cell-cycle and apoptosis readouts, xenograft evidence, and practical supplier-selection criteria.

• Neuroligin 1, D2-MSNs, and Repetitive Behavior

  2026-09-10

  A recent Advanced Science study identifies Neuroligin 1 loss in striatal dopamine D2 receptor-expressing medium spiny neurons as a driver of excessive self-grooming and digging in mice. By combining cell-type-specific manipulation, behavioral analysis, neuronal activity measurements, single-nucleus RNA sequencing, and protein validation, the work links D2-MSN hyperactivation and PKC overactivation to autistic-like repetitive behavior.

• Methyl-β-cyclodextrin Protocol and QC Guide

  2026-09-10

  Methyl-β-cyclodextrin (SKU C6939) supports controlled membrane cholesterol extraction and studies of membrane organization, fluidity, and cholesterol-dependent signaling. It is a research reagent only; working concentration, exposure time, and assay suitability should be established for each biological system, and prepared solutions should not be stored long term.

8502 records 1/567 page Next 12345 下5页 Last page